These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28150698)

  • 21. The behavioral spectrum of Gilles de la Tourette syndrome.
    Cavanna AE; Servo S; Monaco F; Robertson MM
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):13-23. PubMed ID: 19359447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tic syndrome].
    Czapliński A; Steck AJ; Fuhr P
    Neurol Neurochir Pol; 2002; 36(3):493-504. PubMed ID: 12185806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy.
    Rickards H
    Seizure; 1995 Dec; 4(4):259-66. PubMed ID: 8719917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome.
    Forde NJ; Kanaan AS; Widomska J; Padmanabhuni SS; Nespoli E; Alexander J; Rodriguez Arranz JI; Fan S; Houssari R; Nawaz MS; Rizzo F; Pagliaroli L; Zilhäo NR; Aranyi T; Barta C; Boeckers TM; Boomsma DI; Buisman WR; Buitelaar JK; Cath D; Dietrich A; Driessen N; Drineas P; Dunlap M; Gerasch S; Glennon J; Hengerer B; van den Heuvel OA; Jespersgaard C; Möller HE; Müller-Vahl KR; Openneer TJ; Poelmans G; Pouwels PJ; Scharf JM; Stefansson H; Tümer Z; Veltman DJ; van der Werf YD; Hoekstra PJ; Ludolph A; Paschou P
    Front Neurosci; 2016; 10():384. PubMed ID: 27601976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A t(3;9)(q25.1;q34.3) translocation leading to OLFM1 fusion transcripts in Gilles de la Tourette syndrome, OCD and ADHD.
    Bertelsen B; Melchior L; Jensen LR; Groth C; Nazaryan L; Debes NM; Skov L; Xie G; Sun W; Brøndum-Nielsen K; Kuss AW; Chen W; Tümer Z
    Psychiatry Res; 2015 Feb; 225(3):268-75. PubMed ID: 25595337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes.
    Robertson MM
    J Psychosom Res; 2008 Nov; 65(5):473-86. PubMed ID: 18940378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
    Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
    Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coprolalia and copropraxia in patients with Gilles de la Tourette syndrome.
    Kobierska M; Sitek M; Gocyła K; Janik P
    Neurol Neurochir Pol; 2014; 48(1):1-7. PubMed ID: 24636763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate Genes and Pathways Associated with Gilles de la Tourette Syndrome-Where Are We?
    Levy AM; Paschou P; Tümer Z
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gilles de la Tourette syndrome.
    Robertson MM; Stern JS
    Crit Rev Neurobiol; 1997; 11(1):1-19. PubMed ID: 9093811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory Gilles de la Tourette Syndrome-Many Pieces That Define the Puzzle.
    Szejko N; Lombroso A; Bloch MH; Landeros-Weisenberger A; Leckman JF
    Front Neurol; 2020; 11():589511. PubMed ID: 33391155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tics and Gilles de la Tourette syndrome].
    Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial magnetic stimulation in Gilles de la Tourette syndrome.
    Orth M
    J Psychosom Res; 2009 Dec; 67(6):591-8. PubMed ID: 19913663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gilles de la Tourette syndrome: a self-administered assessment questionnaire].
    Usdin M; Mesnage V; Gonce M; Jedynak CP
    Rev Neurol (Paris); 2005 Sep; 161(8-9):795-803. PubMed ID: 16244561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development.
    Muellner J; Delmaire C; Valabrégue R; Schüpbach M; Mangin JF; Vidailhet M; Lehéricy S; Hartmann A; Worbe Y
    Mov Disord; 2015 Apr; 30(5):655-61. PubMed ID: 25820811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in patients with Gilles de la Tourette syndrome at the transition between adolescence and adulthood.
    Silvestri PR; Chiarotti F; Baglioni V; Neri V; Cardona F; Cavanna AE
    Neurol Sci; 2016 Nov; 37(11):1857-1860. PubMed ID: 27457656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
    Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gilles de la tourette syndrome: clinical spectrum and management].
    Calderón González R; Calderón Sepúlveda RF
    Rev Neurol; 2003 Apr 1-15; 36(7):679-88. PubMed ID: 12666050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.